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1. Introduction
  Matrix metalloproteinases (MMPs) are a large family of over 
25 zinc-dependent proteolytic enzymes, which are capable 
of degrading virtually every component of the extracellular 
matrix (ECM), and have been implicated in a variety of 
key normal and pathologic processes, including wound 
healing, organogenesis, inflammation, auto-immunity 
and carcinogenesis. Traditionally, MMPs have been 
subdivided into collagenases, gelatinases, stromelysins, 
and membrane-type MMPs, according to their substrate 
specificity, primary structure, and cellular location[1]. 
Studies over the past 20 years have revealed that MMPs 
play a complex and key role in tumor growth, progression, 
metastasis and angiogenesis[2]. Of MMP family, MMP-2 and 
MMP-9 are mainly involved in the metastasis process. 
  Triptolide (PG490), a diterpene triepoxide, has been 
identified as a crucial active component in extracts of the 
Chinese herb Tripterygium wilfordii Hook F. (TWHF), and 
exerts potent anti-inflammatory, anti-cancer, and anti-
fertility activities in vivo and in vitro[3,4]. Most studies 
indicated that the antitumor activity of triptolide may 
attributes to inhibition of proliferation and induction of 
apoptosis of tumor cells[5-7]. Meanwhile, previous studies 
also showed triptolide as a potent inhibitor of MMPs in some 
cell types. In 2003, Lu et al demonstrated that triptolide 
inhibited the IL-1毬-inducing expression of MMP-1,-2,-3, 
and -9 in corneal fibroblasts at both mRNA and protein 
levels[8]. It is consistent with the previous observation that 
triptolide directly suppressed the production of MMP-1 and 
MMP-3, and simultaneously up-regulated the production 
of tissue inhibitor of metalloproteinase (TIMP)-1 and 
-2 induced by IL-1毩 in human synovial fibroblasts[9]. 
Triptolide also down-regulated the synthesis of MMP-3 
and MMP-13 in chondrocytes partly by interfering with 
the DNA binding activities of transcription factor AP-1 
and NF-毷B[10]. These studies raise the question that 
whether triptolide could down-regulate the expression and 
production of MMPs in tumor microenvironment and thus 
inhibit the invasion and metastasis of tumors.
  In the study, we investigated whether triptolide modulated 
the expression and activities of MMP-2 and MMP-9 in 
human fibrosarcoma HT-1080 cells, and compared its effect 
on invasiveness of the cells with that of anti-MMP-9 in vitro. 
Objective: To explore the molecular mechanisms of antitumor properties of triptolide, a bioactive 
component isolated from the Chinese herb Tripterygium wolfordii Hook F. Methods: Human 
fibrosarcoma HT-1080 cells were treated with different doses of triptolide for 72 h. Then the 
expression and activity of matrix metalloproteinase (MMP)-2 and -9 were measured and the 
invasiveness of triptolide-treated HT-1080 cells was compared with that of anti-MMP-9-
treated HT-1080 cells. Results: 18 nmol/L triptolide inhibited the gene expression and activity 
of MMP-9, but not those of MMP-2, in HT-1080 cells. In addition, both 18 nmol/L triptolide and 3 毺g/mL
anti-MMP-9 significantly reduced the invasive potential of HT-1080 cells, by about 50% and 35%, 
respectively, compared with the control. Whereas there was no significant difference between 
the effect of 18 nmol/L triptolide and that of anti-MMP-9 on invasive potential of HT-1080 cells. 
Conclusions: These data suggest that triptolide inhibits tumor cell invasion partly by reducing 
MMP-9 gene expression and activity.
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2. Materials and methods
2.1. Cell culture and drug treatment
  Human fibrosarcoma HT-1080 cells were purchased from 
the China Center for Type Culture Collection (Wuhan, P. 
R. China) and cultured in MEM containing non- essential 
amino acids (Invitrogen, CA), supplemented with 10% fetal 
bovine serum  (FBS), 100 U/mL penicillin and 100 U/mL
streptomycin. Cells were maintained in a 5% CO2 humidified 
incubator at 37 ℃. Triptolide (PG490, molecular weight 360, 
purity ≥98%) was obtained from Sigma (USA), and prepared 
as previously described[11]. Triptolide was dissolved in 
dimethyl sulfoxide (DMSO) and stock solution (1 mg/mL) and 
was stored at -20 ℃. It was freshly diluted to the indicated 
concentration with MEM before use and directly added to 
cell cultures. The DMSO concentration in all experiments 
never exceeded 0.001% (V/V).
2.2. MTT assay
  The effect of triptolide on cell viability and proliferation 
was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay. Briefly, HT-1080 
cells were seeded in a 96-well plate at a density of 2伊104 
cells per well and incubated overnight. The cells were then 
treated with various concentrations of triptolide (0, 5, 10, 15, 
20, 25, or 30 nmol/L) for 72 h, with changes of reagents every 
24 h (MEM supplemented with just 1% FBS). Next, 20 毺L of 
MTT (Sigma, USA) solution (5 mg/mL in PBS) was added to 
each well and the cells were incubated for additional 4 h at 
37 ℃. MTT solution in medium was aspirated off and 100 毺L
of dimethyl sulfoxide (DMSO) was added to each well before 
absorbance at 492 nm was measured. 
2.3. RNA extraction and reverse transcription PCR 
  Total RNA was extracted from 2.8伊106 cells using TRIzol 
reagent (Invitrogen, CA) according to the manufacturer’s 
instructions, and quantitated by spectrophotometry. 
The integrity and quantity of RNA were verified by 
ethidium bromide staining of the 28S and 18S ribosomal 
RNA bands. First strand cDNA was prepared from 3 毺g
of total RNA in 20 毺L of reaction volume using a 
RevertAid™ First Strand cDNA Synthesis Kit (Ferments, 
Lithuania). After reverse transcription, MMP-9 (sense: 
5’-CAACATCACCTATTGGATCC-3’, and antisense: 5’-
TGGGTGTAGAGTCTCTCGCT-3’ ) ,  MMP-2 (sense: 5’-
GGCCCTGTCACTCCTGAGAT-3’ ,  and antisense:  5’-
GGCATCCAGGTTTCGGGGA-3’), and 毬-actin (sense: 
5’-CGCGAGAAGATGACCCAGAT-3’, and antisense: 5’-
GCACTGTGTTGGCGTACAGG-3’ ) were amplified in a 
TGradient Thermocycler (Whatman Biometra, Germany) as 
follows: 94 ℃ for 4 min, and then 94 ℃ for 30 sec, 55 ℃ for 
50 sec, and 72 ℃ for 60 sec for 30 cycles, and finally, 72 ℃ 
for 10 min. 
2.4. Gelatin zymography
  To measure the activity of MMP-2 and MMP-9, cell-culture 
supernatants (serum-free) were collected and assayed by 
gelatin zymography, using 7.5% SDS-PAGE gels containing 
gelatin (1% w/v; Sigma, MO, USA). After electrophoresis, 
the gels were washed twice for 30 min each in 2.5% Triton 
X-100 to remove SDS and then incubated overnight at 37 ℃ 
in Tris-HCI (pH 7.6), 10 mM CaCl2, 50 mM NaCl, and 0.02% 
Brij-35. After incubation, the gels were stained with 0.25% 
Coomassie brilliant blue R-250 and destained in a solution 
of 40% methanol and 10% acetic acid. 
2.5. Matrigel invasion assay
  HT-1080 cell invasion was assayed using a 6.4 mm 
BD FalconTM cell Culture Insert with an 8.0 毺m pore 
polyethylene terephthalate (PET) membrane (BD Biosciences, 
Durham, NC, USA). Prior to each experiment, the PET filters 
were coated with Growth Factor Reduced BD MatrigelTM 
Matrix (BD Biosciences, Durham, NC, USA). After treatment 
with the indicated concentrations of triptolide or anti-MMP-9 
for 72 h,1伊105 cells, in 0.2 mL of serum-free medium, 
were plated onto the upper compartment of the chamber, 
and the lower chamber was filled with 500 毺L of MEM 
supplemented with 5% FBS. After incubation (without 
triptolide/anti-MMP-9) for another 36 h, the non-invaded 
cells on the upper surface of the membrane were removed 
with a cotton swab, and the invaded cells on the lower 
surface were stained with 0.1% crystal violet for 20 min and 
destained with 33% acetic acid. The eluate was collected, 
and absorbance was measured at 492 nm using a multiwell 
spectrophotometer (Bio-Tek Instruments, Italy).  
2.6. Statistical analysis
  All experiments were performed in triplicate. Data 
were expressed as means依SD and were analyzed using a 
Student`s t-test, with P values less than 0.05 as statistically 
significant. Statistical analyses were performed using SPSS 
software.
3. Results
3.1. Cytotoxic effect of triptolide on HT-1080 cells 
  As shown in Figure 1, triptolide IC50 for HT-1080 cells 
was about 25 nmol/L after 72 h of treatment. Thus, doses of 
triptolide in following experiments were 6, 12, and 18 nmol/L 
to exclude toxicity.
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Figure 1.  Effect of triptolide on proliferation of HT-1080 cells. 
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3.2. Effects of triptolide on the mRNA expression and activity 
of MMP-2 and MMP-9
  Figure 2 showed that triptolide significantly inhibited the 
gene expression of MMP-9 at a concentration of 18 nmol/L,
compared with the control (0.36依0.04 versus 0.59依0.11, P 
<0.05 ). However, triptolide at indicated concentration had 
no inhibitive effect on the mRNA expression of MMP-2 in 
HT-1080 cells. 
  Results also showed that 18 nmol/L triptolide reduced 
MMP-9 activity almost completely but had little effect on 
MMP-2 activity (Figure 3). 
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Figure 2.  Effect of triptolide on the mRNA expression of MMP-2 and 
MMP-9 in HT-1080 cells. 
(A) RT-PCR result of MMP-2 and MMP-9 expression. Marker = 100 
bp ladder; (B) Fold change of MMP-2 and MMP-9 expression, * P < 
0.05 compared with control.
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Figure 3.  Effect of triptolide on the activity of MMP-2 and MMP-9 
in HT-1080 cells.
(A) Content of gelatinases in serum-free supernatants; (B) Relative 
activity of MMP-2 and MMP-9, *P<0.05 and # P<0.01 compared 
with control.
3.3. Effect of triptolide on HT-1080 cell invasion  
  The modified Matrigel invasion assay showed that 
compared with the control, incubation with 18 nmol/L 
triptolide or 3 毺g/mL anti-MMP-9 for 72 h significantly 
reduced the number of HT-1080 cells which invaded through 
the Matrigel coating, by about 50% and 35%, respectively,. 
However, no significant difference was found between the 
invasiveness of 18 nmol/L triptolide treated HT-1080 cells 
and that of anti-MMP-9 treated cells (Figure 4), 
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Figure 4.  Effect of triptolide on invasiveness of HT-1080 cells in 
vitro. (A) Electroscopic result of HT-1080 cells; (B) Absorbance 
value, * P < 0.05 compared with control.
4. Discussion
  Most cancer patients do not die from local complications of 
their primary tumor growth, but rather from the development 
and spread of the tumor. Therefore, metastasis is one of 
hallmarks of malignant tumor and a major cause of death 
among cancer patients. Several reports have indicated that 
triptolide can reduce the growth and metastasis of tumors 
in vivo and in vitro, via inhibition of heat shock protein 70 
(HSP70), CXC chemokine receptor 4 (CXCR4), or urokinase-
type plasminogen activator receptor (uPAR)[5,12,13].
In the present study, we demonstrated that triptolide 
effectively inhibited the invasion of highly matastatic human 
fibrosarcoma HT-1080 cells to extracellular matrix (ECM) at 
a nontoxic concentration, implying the potent antimetastic 
activity of triptolide.
  Neoplasm metastasis involves a series of complex 
processes that spread tumor cells from the primary site to 
a distant location. MMP-9, also known as gelatinase B, has 
been involved in many steps of tumor metastasis, including 
tumor growth, invasion, migration, host immune escape, 
extravasation and angiogenesis[2,14-16]. In this study, we 
showed that 18 nmol/L triptolide inhibited almost completely 
the gene expression and activity of MMP-9 in HT-1080 
cells. The data suggest that the anti-metastatic activity 
of triptolide might be, at least partly, due to inhibition of 
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MMP-9.
  Furthermore, our experiments also showed that the 
invasion ability of 18nmol/L triptolide treated HT-1080 
cells was much lower than that of anti-MMP-9 treated cells, 
though no significant difference was detected between each 
other. These results indicate that triptolide may inhibit 
HT-1080 cell metastasis through mechanisms other than 
downregulating MMP-9 expression.
  On the other hand, culture of HT-1080 cells treated with 
18nmol/L triptolide also had a high number of invading 
cells, which might be due to the long incubating time and 
the high invasive potential of HT-1080 cells.
  Although MMP-9 shares fairly broad substrate specificity 
and structural features with MMP-2, both enzymes differ 
considerably in terms of transcriptional regulation. The 5’ 
flanking sequence of the MMP-9 gene harbors TATA boxes 
and several consensus motifs for AP-1, NF-κB, Sp-1, 
and Ets transcription factors, and transcription of the gene 
requires synergistic cooperation of AP-1 with either NF-κB 
or Sp-1[17, 18]. In contrast, the promoter of MMP-2 contains 
no AP-1 binding site nor TATA box, and the expression of 
this gene is mainly determined by Sp-1, which binds to a 
proximal GC box [17]. These could be presumed to be one of 
the reasons for the different effect of triptolide on the gene 
expression of MMP-9, compared with MMP-2.
  Our previous study demonstrated that triptolide up-
regulated the DNA methylation level of MMP-9 gene in HT-
1080 cells[19]. Furthermore, Chicoine et al found an inverse 
correlation between level of methylation of the MMP-9 
promoter and the level of MMP-9 expression in a series 
of lymphoma cell lines[20]. Given the importance of DNA 
methylation pattern in gene expression, further studies are 
required to investigate whether triptolide inhibits MMP-9 
expression by elevated DNA methylation level of the gene in 
a variety of cells.
  T h e  o v e r - e x p r e s s i o n  o f  M M Ps  i n  t h e  t u m o r 
microenvironment depends not only on the cancer cells, but 
also on the neighboring stromal cells, which are induced by 
the cancer cells in a paracrime manner. To determine the 
effect of triptolide exert on MMPs expression in other cell 
types, further studies are required also. 
  In conclusion, we demonstrated that triptolide inhibited 
the invasiveness of human fibrosarcoma HT-1080 cells in 
vitro, partly by directly reducing MMP-9 gene expression 
and activity. Our results cast new light on the molecular 
mechanisms underlying the anti-tumor effects of triptolide.
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